Drug recall · February 15, 2023
Posaconazole Delayed-Release Tablets recall
Why: Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009; Manufactured by: Biocon Pharma Limited, Bengaluru, India - 560 099, NDC 70377-038-11.
- Lots / codes
Lot #: BF21003163, BF21003246, BF21003161, Exp. Sep-2023; BF21004742, Exp. Dec-2023; BF22003359, Exp. Sep-2025
- Quantity
- 3665 bottles
- Company
- Biocon Pharma Inc, Iselin, NJ
- Distribution
- Nationwide in the USA
- Initiated
- January 31, 2023 · Voluntary: Firm initiated
- Classified
- February 14, 2023
- Reported
- February 15, 2023
- Ended
- June 21, 2024
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Posaconazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.